It blocks a step that turns testosterone into a stronger hormone in hair roots and the prostate. The EndoText excerpt explains the hormone process behind Finasteride, a prescription medicine. It describes how hormones work in human tissues, rather than reporting one new study. The supplied passage does not give a group size, dose comparison, or measured treatment results. Here’s the key idea: testosterone’s effects depend partly on where it acts. In the prostate and hair roots, a protein helps convert testosterone into DHT (Dihydrotestosterone), a stronger hormone. That conversion boosts the hormone’s action within those tissues. Blocking this step was the basis for developing Finasteride. This explains how the medicine works, not how much someone will benefit. The excerpt gives no percentage drop in hormone levels. It also gives no numbers for hair growth or prostate changes. It lists papers about prostate cancer, but their full results aren’t shown here. Those references alone cannot settle questions about cancer risk. For BioSocial members, this offers context for a tracking log. A medicine’s target and a person’s observed results are different pieces of information. Bloodwork, dated hair photos, and notes about changes can sit alongside each other. This passage does not establish how closely those measures should match. Comparing notes with the community can keep those distinctions clear. Including dates and time on the medicine makes experiences easier to compare. It also helps separate what you measured from what you noticed. What changes have you tracked while using Finasteride, and how have your numbers compared with your experience?